TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT05526391 updates: 1. start date: 2022-11-09 → 2022-11-16 2. enrollment: 159 → 158 participants
Clinical trial NCT05526391 updates: 1. start date: 2022-11-09 → 2022-11-16 2. enrollment: 159 → 158 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical